Inclusion Criteria : 
  1.  Moderate / severe hypertensive left ventricular ( LV ) hypertrophy ( LVMi ≥ 109 g / m² in women and ≥ 132 g / m² in men ) ;
  2.  New York Heart Association ( NYHA ) class II - III heart failure;
  3.  Left ventricular ejection fraction > 50 %;
  4.  Increased LV filling pressures assessed at rest or at peak exercise by echocardiography
  5.  Body mass index ( BMI ) > 30 kg / m²
  6.  Signed and data informed consent
Exclusion Criteria : 
  1.  Age ≤ 18 years;
  2.  Evidence of myocardial ischemia during stress echocardiography;
  3.  Chronic atrial flutter or atrial fibrillation;
  4.  Alternative cause of left ventricular hypertrophy and impaired diastolic function ( hypertrophic / restictive cardiomyopathy , aortic stenosis , constrictive pericarditis and etc. ) ;
  5.  NYHA classification I or decompensated heart failure at screening;
  6.  Systolic blood pressure < 110 mmHg or > 180 mmHg;
  7.  Diastolic blood pressure < 40 mmHg or > 100 mmHg;
  8.  Anemia ( Hb < 100 g / l ) ;
  9.  Significant left sided structural valve disease;
 10.  Secondary hypertension;
 11.  Dyspnea due to non - cardiac causes such as pulmonary disease , anemia , severe obesity , primary valvular , or myocardial diseases;
 12.  Myocardial infarction or myocardial revascularization within the last 3 months of screening;
 13.  Stroke or TIA within the last 3 months of screening;
 14.  Autoimmunic and oncological diseases;
 15.  Impaired renal function , defined as eGFR < 30 ml / min / 1.73 m²;
 16.  Impaired liver function;
 17.  Potassium concentration > 5.2 mmol / L.